Endoscopic Delivery of Polymers Reduces Delayed Bleeding after Gastric Endoscopic Submucosal Dissection: A Systematic Review and Meta-Analysis
- PMID: 35745963
- PMCID: PMC9227627
- DOI: 10.3390/polym14122387
Endoscopic Delivery of Polymers Reduces Delayed Bleeding after Gastric Endoscopic Submucosal Dissection: A Systematic Review and Meta-Analysis
Abstract
New endoscopic approaches for the prevention of delayed bleeding (DB) after gastric endoscopic submucosal dissection (ESD) have been reported in recent years, and endoscopic delivery of biodegradable polymers for iatrogenic ulcer hemostasis and coverage has emerged as one of the most promising techniques for post-ESD management. However, the comparative efficacy of these techniques remains uncertain. We performed a systematic search of multiple databases up to May 2022 to identify studies reporting DB rates as outcomes in patients undergoing gastric ESD who were treated with subsequent endoscopic management, including endoscopic closure (clip-based methods and suturing), PGA sheet tissue shielding, and hemostatic powder/gel spray (including polymeric sealants and other adhesives). The risk ratios (RRs) of delayed bleeding in treatment groups and control groups were pooled, and the Bayesian framework was used to perform a network meta-analysis (NMA). Among these studies, 16 head-to-head comparisons that covered 2742 lesions were included in the NMA. Tissue shielding using PGA sheets significantly reduced the risk of DB by nearly two thirds in high-risk patients, while hemostatic spray systems, primarily polymer-based, reduced DB in low-risk patients nine-fold. Researchers should recognize the essential role of polymers in the management of ESD-induced ulcers, and develop and validate clinical application strategies for promising materials.
Keywords: delayed bleeding; endoscopic closure; endoscopic submucosal dissection; hemostatic spray; polyglycolic acid; polymers.
Conflict of interest statement
The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Figures
References
-
- Pimentel-Nunes P., Dinis-Ribeiro M., Ponchon T., Repici A., Vieth M., De Ceglie A., Amato A., Berr F., Bhandari P., Bialek A., et al. Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2015;47:829–854. doi: 10.1055/s-0034-1392882. - DOI - PubMed
-
- Uedo N., Takeuchi Y., Yamada T., Ishihara R., Ogiyama H., Yamamoto S., Kato M., Tatsumi K., Masuda E., Tamai C., et al. Effect of a proton pump inhibitor or an H2-receptor antagonist on prevention of bleeding from ulcer after endoscopic submucosal dissection of early gastric cancer: A prospective randomized controlled trial. Am. J. Gastroenterol. 2007;102:1610–1616. doi: 10.1111/j.1572-0241.2007.01197.x. - DOI - PubMed
-
- Niimi K., Fujishiro M., Goto O., Kodashima S., Minatsuki C., Hirayama I., Mochizuki S., Ono S., Yamamichi N., Kakushima N., et al. Prospective single-arm trial of two-week rabeprazole treatment for ulcer healing after gastric endoscopic submucosal dissection. Dig. Endosc. Off. J. Jpn. Gastroenterol. Endosc. Soc. 2012;24:110–116. doi: 10.1111/j.1443-1661.2011.01178.x. - DOI - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
